{"id":"W2600008150","doi":"10.1200/jco.2012.30.15_suppl.8020","title":"A randomized phase II study of elotuzumab with lenalidomide and low-dose dexamethasone in patients with relapsed/refractory multiple myeloma.","year":2012,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lenalidomide; Dexamethasone; Thalidomide; Multiple myeloma; Refractory (planetary science); Bortezomib; Internal medicine; Phases of clinical research; Progressive disease; Gastroenterology; Toxicity; Urology; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002307705,0.002062898,0.002757158,0.000502523,0.0004555112,0.001256021,0.001256382,0.001725621,0.00909989],"category_scores_gemma":[0.001494026,0.0009100735,0.001255771,0.0005332014,0.001348949,0.001176862,0.0005762613,0.003257352,0.001637222],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001272605,"about_ca_system_score_gemma":0.00188213,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00114354,"about_ca_topic_score_gemma":0.002454312,"domain_scores_codex":[0.9992387,0.0004289967,0.00003946594,0.0001301535,0.00004864687,0.000114139],"domain_scores_gemma":[0.9988582,0.0002116414,0.0002068778,0.00009028767,0.00005699996,0.0005760537],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9552441,0.02518847,0.001120382,0.0002293879,0.000396411,0.00005273859,0.00005832076,0.0003491146,0.003116501,0.00009044809,0.0007413204,0.01341278],"study_design_scores_gemma":[0.9275791,0.07018895,0.00104227,0.00001028255,0.000121545,0.00002670874,0.00001546189,0.0002086111,0.0001836109,0.00007641853,0.0005399294,0.00000718351],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9806582,0.00238532,0.0007054882,0.000809933,0.0005538678,0.01086495,0.001300844,0.0001138096,0.002607699],"genre_scores_gemma":[0.9720427,0.002231714,0.002526351,0.002652257,0.0006372637,0.0125421,0.00277304,0.00004365531,0.004550843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00909989,"threshold_uncertainty_score":0.03044218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08419696088202684,"score_gpt":0.4406944511476423,"score_spread":0.3564974902656155,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}